Pathos AI Partners with BMS and Tempus to Advance Alzheimer’s Drug Research
Pathos AI has announced strategic collaborations with Bristol Myers Squibb (BMS) and Tempus AI to use artificial intelligence (AI) to advance drug development for Alzheimer’s disease…
Read More...
Read More...
